GH
MRVI icon

GAM Holding’s Maravai LifeSciences MRVI Stock Holding History

GAM Holding’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-42,198
Closed -$422K – 175
2023
Q3 		$422K Buy
42,198
+72
+0.2% +$791 0.03% 163
2023
Q2 		$524K Sell
42,126
-13
-0% -$175 0.04% 174
2023
Q1 		$590K Buy
42,139
+448
+1% +$6.43K 0.04% 185
2022
Q4 		$597K Sell
41,691
-170
-0.4% -$2.68K 0.05% 184
2022
Q3 		$1.07M Sell
41,861
-121
-0.3% -$3.04K 0.08% 170
2022
Q2 		$1.19M Buy
41,982
+13,998
+50% +$443K 0.08% 178
2022
Q1 		$987K Sell
27,984
-11,769
-30% -$395K 0.05% 201
2021
Q4 		$1.67M Buy
39,753
+5,420
+16% +$220K 0.07% 179
2021
Q3 		$1.69M Buy
34,333
+9,570
+39% +$467K 0.08% 180
2021
Q2 		$1.03M Buy
+24,763
New +$960K 0.04% 224

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

GAM Holding's MRVI Position: Q4 2023 in Review

GAM Holding sold out of Maravai LifeSciences (MRVI) in Q4 2023, closing a stake of 42,198 shares — an estimated $422K sold.

GAM Holding first reported a position in MRVI in Q2 2021 and held it in 10 quarters. The position peaked at $1.69M in Q3 2021. 223 funds tracked by Wall St. Rank hold MRVI as of Q4 2023.

  • GAM Holding reported no remaining Maravai LifeSciences position as of Q4 2023 after selling out during the quarter.
  • GAM Holding sold 42,198 Maravai LifeSciences shares in Q4 2023, an estimated $422K.
  • GAM Holding first reported a position in Maravai LifeSciences in Q2 2021 and held it in 10 quarters.
  • GAM Holding's Maravai LifeSciences position peaked at $1.69M in Q3 2021.
  • 223 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2023.

Based on GAM Holding's 13F filing for Q4 2023, filed 23 Jan 2024.